COMPARISON OF THE POTENTIAL OF THE 2 EPIPODOPHYLLOTOXIN DERIVATIVES VP-16 AND VM-26 ON SMALL CELL-CANCER OF THE LUNG (SOCL) CELL-LINES

被引：0

作者：

ROED, H

VINDELOV, LL

CHRISTENSEN, IJ

HANSEN, HH

SPANGTHOMSEN, M

机构：

[1] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK

[2] UNIV COPENHAGEN,INST PATHOL ANAT,DK-1168 COPENHAGEN K,DENMARK

来源：

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：334 / 334

页数：1

共 50 条

[1] THE EFFECT OF THE 2 EPIPODOPHYLLOTOXIN DERIVATIVES ETOPOSIDE (VP-16) AND TENIPOSIDE (VM-26) ON CELL-LINES ESTABLISHED FROM PATIENTS WITH SMALL CELL-CARCINOMA OF THE LUNG
ROED, H
VINDELOV, LL
CHRISTENSEN, IJ
SPANGTHOMSEN, M
HANSEN, HH
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (01) : 16 - 20
[2] MECHANISM OF CELLULAR TRANSPORT OF 2 EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES, VM-26(VM) AND VP-16(VP)
ALLEN, LM
SHIRLEY, M
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 22 - 22
[3] COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES
ALLEN, LM
CREAVEN, PJ
EUROPEAN JOURNAL OF CANCER, 1975, 11 (10) : 697 - 707
[4] ANTITUMOR-ACTIVITY OF THE 2 EPIPODOPHYLLOTOXIN DERIVATIVES VP-16 AND VM-26 IN PRECLINICAL SYSTEMS - A COMPARISON OF INVITRO AND INVIVO DRUG-EVALUATION
JENSEN, PB
ROED, H
SKOVSGAARD, T
FRICHE, E
VINDELOV, L
HANSEN, HH
SPANGTHOMSEN, M
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (03) : 194 - 198
[5] COMPARISON BETWEEN VP-16 AND VM-26 IN LEWIS LUNG-CARCINOMA OF THE MOUSE
COLOMBO, T
BROGGINI, M
VAGHI, M
AMATO, G
ERBA, E
DINCALCI, M
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (02): : 173 - 179
[6] CELLULAR PHARMACOKINETICS OF TWO EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES, VM-26 (VM) AND VP-16 (VP) - UPTAKE IN PRESENCE AND ABSENCE OF HUMAN-SERUM ALBUMIN (HSA)
ALLEN, L
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 125 - 125
[7] ACTIVITY OF ETOPOSIDE (VP-16) AND TENIPOSIDE (VM-26) IN EXPONENTIAL AND PLATEAU PHASE HUMAN TUMOR-CELL CULTURES
CHAPUIS, JC
KENG, PC
SIEMANN, DW
ANTI-CANCER DRUGS, 1992, 3 (03) : 245 - 252
[8] Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin
Jain, N
Lam, YM
Pym, J
Campling, BG
CANCER, 1996, 77 (09) : 1797 - 1808
[9] TOPOISOMERASE-II-MEDIATED LESIONS IN NASCENT DNA - COMPARISON OF THE EFFECTS OF EPIPODOPHYLLOTOXIN DERIVATIVES, VM-26 AND VP-16, AND 9-ANILINOACRIDINE DERIVATIVES, META-AMSA AND ORTHO-AMSA
WOYNAROWSKI, JM
SIGMUND, RD
BEERMAN, TA
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 950 (01) : 21 - 29
[10] VP-16 VS POLYCHEMOTHERAPY IN SMALL CELL LUNG-CANCER
EAGAN, RT
FRYTAK, S
RUBIN, J
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 243 - 243

← 1 2 3 4 5 →